Tissue engineering of human bladder

British Medical Bulletin

Volumn 97, Issue 1, 2011, Pages 81-104

  Atala, Anthony ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

biomaterials; bladder; cystectomy; reconstruction; regenerative medicine; stem cells; tissue engineering

Indexed keywords

ALGINIC ACID; BIOMATERIAL; COLLAGEN; POLY(LACTIC CO GLYCOLIC ACID); POLYGLYCOLIC ACID; POLYLACTIC ACID; SILICONE; UNCLASSIFIED DRUG;

ADULT STEM CELL; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BIODEGRADABLE IMPLANT; BIOMEDICAL ENGINEERING; BLADDER; BLADDER NECK; BLADDER RECONSTRUCTION; BLADDER SPHINCTER PROSTHESIS; BLADDER WALL; CELL ADHESION; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CROSS LINKING; CYSTECTOMY; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; HEMATOPOIETIC STEM CELL; HUMAN; IMMOBILIZED CELL; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; STEM CELL; SUBMUCOSA; TISSUE ENGINEERING; TISSUE REGENERATION; URINE INCONTINENCE; VESICOURETERAL REFLUX;

ANIMALS; BIOCOMPATIBLE MATERIALS; HUMANS; REGENERATION; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; URINARY BLADDER;

EID: 79952570027     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldr003     Document Type: Article

References (157)

1. McDougal WS. Metabolic complications of urinary intestinal diversion. J Urol 1992;147:1199-208.
2. Atala A, Bauer SB, Hendren WH et al. The effect of gastric augmentation on bladder function. J Urol 1993;149:1099-102. (Pubitemid 23133782)
3. Kaefer M, Hendren WH, Bauer SB et al. Reservoir calculi: a comparison of reservoirs constructed from stomach and other enteric segments [see comment]. J Urol 1998;160:2187-90. (Pubitemid 128703650)
4. Kaefer M, Tobin MS, Hendren WH et al. Continent urinary diversion: the Children's Hospital experience. J Urol 1997;157:1394-9. (Pubitemid 27130832)
5. Cartwright PC, Snow BW. Bladder autoaugmentation: partial detrusor excision to augment the bladder without use of bowel. J Urol 1989;142:1050-3. (Pubitemid 19250765)
6. Cartwright PC, Snow BW. Bladder autoaugmentation: early clinical experience. J Urol 1989;142:505-8; discussion 520-1. (Pubitemid 19193656)
7. Bellinger MF. Ureterocystoplasty: a unique method for vesical augmentation in children. J Urol 1993;149:811-3. (Pubitemid 23111074)
8. Churchill BM, Aliabadi H, Landau EH et al. Ureteral bladder augmentation. J Urol 1993;150:716-20. (Pubitemid 23213727)
9. Adams MC, Brock JW III, Pope JCt et al. Ureterocystoplasty: is it necessary to detubularize the distal ureter? J Urol 1998;160:851-3. (Pubitemid 29479541)
10. Atala A, Peters CA, Retik AB et al. Endoscopic treatment of vesicoureteral reflux with a selfdetachable balloon system. J Urol 1992;148:724-7.
11. Riehmann M, Gasser TC, Bruskewitz RC. The Hydroflex penile prosthesis: a test case for the introduction of new urological technology. J Urol 1993;149:1304-7. (Pubitemid 23133835)
12. Levesque PE, Bauer SB, Atala A et al. Ten-year experience with the artificial urinary sphincter in children. J Urol 1996;156:625-8. (Pubitemid 126444889)
13. Buckley JF, Scott R, Aitchison M. Periurethral microparticulate silicone injection for stress incontinence and vesicoureteric reflux. Minim Invasive Ther 1997;1:72.
14. Atala A. Use of non-autologous substances in VUR and incontinence treatment. Dial Pediatr Urol 1994;17:11-2.
15. Alberts B, Bray D, Lewis JM. The extracellular matrix of animals. In: Alberts B, Bray D, Lewis JM (eds). Molecular Biology of the Cell. New York, NY: Garland Publishing, 1994,971-95.
16. Kim BS, Mooney DJ. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol 1998;16:224-30.
17. Ponder KP, Gupta S, Leland F et al. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci USA 1991;88:1217-21. (Pubitemid 21916196)
18. Brittberg M, Lindahl A, Nilsson A et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation [see comment]. N Engl J Med 1994;331:889-95. (Pubitemid 24299869)
19. Bergsma JE, Rozema FR, Bos RR et al. In vivo degradation and biocompatibility study of in vitro pre-degraded as-polymerized polyactide particles [see comment]. Biomaterials 1995;16:267-74.
20. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
21. Deuel TF. Growth factors. In: Lanza R, Langer R, Chick WL (eds). Principles of Tissue Engineering. New York, NY: Academic Press, 1997,133-49.
22. Barrera DA, Zylstra E, Lansbury PT et al. Synthesis and RGD peptide modification of a new biodegradable copolymer poly (lactic acid-co-lysine). J Am Chem Soc 1993;115:11010-1.
23. Cook AD, Hrkach JS, Gao NN et al. Characterization and development of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial. J Biomed Mater Res 1997;35:513-23. (Pubitemid 27250915)
24. Eberli D, Freitas Filho L, Atala A et al. Composite scaffolds for the engineering of hollow organs and tissues. Methods (Duluth) 2009;47:109-15.
25. Atala A. Engineering tissues, organs and cells. J Tissue Eng Regen Med 2007;1:83-96.
26. Yoo JJ, Lee JE, Kim HJ et al. Comparative in vitro and in vivo studies using a bioactive poly(epsilon-caprolactone)-organosiloxane nanohybrid containing calcium salt. J Biomed Mater Res Part B Appl Biomater 2007;83:189-98.
27. Lee SJ, Van Dyke M, Atala A et al. Host cell mobilization for in situ tissue regeneration. Rejuvenation Res 2008;11:747-56.
28. Choi JS, Lee SJ, Christ GJ et al. The influence of electrospun aligned poly(epsiloncaprolactone)/ collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes. Biomaterials 2008;29:2899-906.
29. Lee SJ, Liu J, Oh SH et al. Development of a composite vascular scaffolding system that withstands physiological vascular conditions. Biomaterials 2008;29:2891-8.
30. Lee SJ, Oh SH, Liu J et al. The use of thermal treatments to enhance the mechanical properties of electrospun poly(epsilon-caprolactone) scaffolds. Biomaterials 2008;29:1422-30.
31. Lee SJ, Yoo JJ, Lim GJ et al. In vitro evaluation of electrospun nanofiber scaffolds for vascular graft application. J Biomed Mater Res Part A 2007;83:999-1008. (Pubitemid 350231760)
32. Pariente JL, Kim BS, Atala A. In vitro biocompatibility assessment of naturally derived and synthetic biomaterials using normal human urothelial cells. J Biomed Mater Res 2001;55:33-9. (Pubitemid 32157784)
33. Li ST. Biologic biomaterials: tissue derived biomaterials (collagen). In: JD B (ed). The Biomedical Engineering Handbook. Boca Raton, FL: CRS Press, 1995,627-47.
34. Furthmayr H, Timpl R. Immunochemistry of collagens and procollagens. Int Rev Connect Tissue Res 1976;7:61-99.
35. Cen L, Liu W, Cui L et al. Collagen tissue engineering: development of novel biomaterials and applications. Pediatr Res 2008;63:492-6. (Pubitemid 351572218)
36. Silver FH, Pins G. Cell growth on collagen: a review of tissue engineering using scaffolds containing extracellular matrix. J Long Term Eff Med Implants 1992;2:67-80. (Pubitemid 23626477)
37. Sams AE, Nixon AJ. Chondrocyte-laden collagen scaffolds for resurfacing extensive articular cartilage defects. Osteoarthritis Cartilage 1995;3:47-59.
38. Yannas IV, Burke JF, Gordon PL et al. Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res 1980;14:107-32.
39. Yannas IV, Burke JF. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res 1980;14:65-81. (Pubitemid 10166784)
40. Cavallaro JF, Kemp PD, Kraus KH. Collagen fabrics as biomaterials. Biotechnol Bioeng 1994;43:781-91. (Pubitemid 24127954)
41. Smidsrod O, Skjak-Braek G. Alginate as immobilization matrix for cells. Trends Biotechnol 1990;8:71-8.
42. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999;20:45-53. (Pubitemid 29002544)
43. Campbell PG, Weiss LE. Tissue engineering with the aid of inkjet printers. Expert Opin Biol Ther 2007;7:1123-7. (Pubitemid 47305243)
44. Boland T, Xu T, Damon B et al. Application of inkjet printing to tissue engineering. Biotechnol J 2006;1:910-7.
45. Nakamura M, Kobayashi A, Takagi F et al. Biocompatible inkjet printing technique for designed seeding of individual living cells. Tissue Eng 2005;11:1658-66. (Pubitemid 43120177)
46. Laflamme MA, Gold J, Xu C et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 2005;167:663-71. (Pubitemid 41216352)
47. Xu T, Rohozinski J, Zhao W et al. Inkjet-mediated gene transfection into living cells combined with targeted delivery. Tissue Eng Part A 2009;15:95-101.
48. Ilkhanizadeh S, Teixeira AI, Hermanson O. Inkjet printing of macromolecules on hydrogels to steer neural stem cell differentiation. Biomaterials 2007;28:3936-43. (Pubitemid 47048366)
49. Roth EA, Xu T, Das M et al. Inkjet printing for high-throughput cell patterning. Biomaterials 2004;25:3707-15. (Pubitemid 38327059)
50. Dahms SE, Piechota HJ, Dahiya R et al. Composition and biomechanical properties of the bladder acellular matrix graft: comparative analysis in rat, pig and human. Br J Urol 1998;82:411-9. (Pubitemid 28434618)
51. Piechota HJ, Dahms SE, Nunes LS et al. In vitro functional properties of the rat bladder regenerated by the bladder acellular matrix graft. J Urol 1998;159:1717-24. (Pubitemid 29117390)
52. Yoo JJ, Meng J, Oberpenning F et al. Bladder augmentation using allogenic bladder submucosa seeded with cells. Urol 1998;51:221-5. (Pubitemid 28093171)
53. Chen F, Yoo JJ, Atala A. Acellular collagen matrix as a possible 'off the shelf' biomaterial for urethral repair. Urol 1999;54:407-10. (Pubitemid 29407010)
54. Probst M, Dahiya R, Carrier S et al. Reproduction of functional smooth muscle tissue and partial bladder replacement. Br J Urol 1997;79:505-15. (Pubitemid 28321090)
55. Gilding D. Biodegradable polymers. In: Williams D (ed). Biocompatibility of Clinical Implant Materials. Boca Raton, FL: CRC Press, 1981,209-32.
56. Freed LE, Vunjak-Novakovic G, Biron RJ et al. Biodegradable polymer scaffolds for tissue engineering. Biotechnology (NY) 1994;12:689-93.
57. Mikos AG, Lyman MD, Freed LE et al. Wetting of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams for tissue culture. Biomaterials 1994;15:55-8.
58. Harris LD, Kim BS, Mooney DJ. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res 1998;42:396-402. (Pubitemid 28452514)
59. Han D, Gouma PI. Electrospun bioscaffolds that mimic the topology of extracellular matrix. Nanomedicine 2006;2:37-41.
60. Intveld PJA, Shen ZR, Takens GAJ. Glycine glycolic acid based copolymers. J Polym Sci Polym Chem 1994;32:1063-9.
61. Peppas NA, Langer R. New challenges in biomaterials [see comment]. Science 1994;263:1715-20. (Pubitemid 24131582)
62. Boccaccini AR, Blaker JJ. Bioactive composite materials for tissue engineering scaffolds. Expert Rev Med Devices 2005;2:303-17. (Pubitemid 40691963)
63. Harrison BS, Atala A. Carbon nanotube applications for tissue engineering. Biomaterials 2007;28:344-53. (Pubitemid 44537381)
64. Harrington DA, Cheng EY, Guler MO et al. Branched peptide-amphiphiles as selfassembling coatings for tissue engineering scaffolds. J Biomed Mater Res A 2006;78:157-67. (Pubitemid 44032538)
65. Atala A, Vacanti JP, Peters CA et al. Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro. J Urol 1992;148:658-62.
66. Atala A, Cima LG, Kim W et al. Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux. J Urol 1993;150:745-7. (Pubitemid 23213733)
67. Atala A, Freeman MR, Vacanti JP et al. Implantation in vivo and retrieval of artificial structures consisting of rabbit and human urothelium and human bladder muscle. J Urol 1993;150:608-12. (Pubitemid 23213699)
68. Atala A, Kim W, Paige KT et al. Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension. J Urol 1994;152:641-3; discussion 644.
69. Atala A. Tissue engineering, stem cells, and cloning for the regeneration of urologic organs. Clin Plast Surg 2003;30:649-67. (Pubitemid 37351936)
70. Atala A. Recent applications of regenerative medicine to urologic structures and related tissues. Curr Opin Urol 2006;16:305-9. (Pubitemid 43904286)
71. Cilento BG, Freeman MR, Schneck FX et al. Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. J Urol 1994;152:665-70. (Pubitemid 24235877)
72. Scriven SD, Booth C, Thomas DF et al. Reconstitution of human urothelium from monolayer cultures. J Urol 1997;158:1147-52. (Pubitemid 127739801)
73. Liebert M, Hubbel A, Chung M et al. Expression of mal is associated with urothelial differentiation in vitro: identification by differential display reverse-transcriptase polymerase chain reaction. Differentiation 1997;61:177-85. (Pubitemid 27099867)
74. Puthenveettil JA, Burger MS, Reznikoff CA. Replicative senescence in human uroepithelial cells. Adv Exp Med Biol 1999;462:83-91.
75. Atala A, Schlussel RN, Retik AB. Renal cell growth in vivo after attachment to biodegradable polymer scaffolds. J Urol 1995;153.
76. Atala A, Guzman L, Retik AB. A novel inert collagen matrix for hypospadias repair. J Urol 1999;162:1148-51. (Pubitemid 29434692)
77. Atala A. Tissue engineering in the genitourinary system. In: Atala A, Mooney DJ (eds). Tissue Engineering. Boston, MA: Birkhauser Press, 1997,149.
78. Atala A. Autologous cell transplantation for urologic reconstruction. J Urol 1998;159:2-3. (Pubitemid 127739867)
79. Yoo JJ, Atala A. A novel gene delivery system using urothelial tissue engineered neo-organs. J Urol 1997;158:1066-70.
80. Fauza DO, Fishman SJ, Mehegan K et al. Videofetoscopically assisted fetal tissue engineering: skin replacement. J Pediatr Surg 1998;33:357-61. (Pubitemid 28093729)
81. Fauza DO, Fishman SJ, Mehegan K et al. Videofetoscopically assisted fetal tissue engineering: bladder augmentation. J Pediatr Surg 1998;33:7-12. (Pubitemid 28060370)
82. Machluf M, Atala A. Emerging concepts for tissue and organ transplantation. Graft 1998;1:31-7.
83. Amiel GE, Atala A. Current and future modalities for functional renal replacement. Urol Clin N Am 1999;26:235-46. (Pubitemid 29104702)
84. Kershen RT, Atala A. New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux. Urol Clin N Am 1999;26:81-94. (Pubitemid 29104691)
85. Oberpenning F, Meng J, Yoo JJ et al. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering [see comment]. Nat Biotechnol 1999;17:149-55. (Pubitemid 29072538)
86. Park HJ, Yoo JJ, Kershen RT et al. Reconstitution of human corporal smooth muscle and endothelial cells in vivo. J Urol 1999;162:1106-9. (Pubitemid 29434681)
87. Liebert M, Wedemeyer G, Abruzzo LV et al. Stimulated urothelial cells produce cytokines and express an activated cell surface antigenic phenotype. Semin Urol 1991;9:124-30.
88. Tobin MS, Freeman MR, Atala A. Maturational response of normal human urothelial cells in culture is dependent on extracellular matrix and serum additives. Surg Forum 1994;45:786.
89. Harriss DR. Smooth muscle cell culture: a new approach to the study of human detrusor physiology and pathophysiology. Br J Urol 1995;75(Suppl. 1):18-26.
90. Freeman MR, Yoo JJ, Raab G et al. Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J Clin Invest 1997;99:1028-36. (Pubitemid 27123640)
91. Solomon LZ, Jennings AM, Sharpe P et al. Effects of short-chain fatty acids on primary urothelial cells in culture: implications for intravesical use in enterocystoplasties [see comment]. J Lab Clin Med 1998;132:279-83. (Pubitemid 28490260)
92. Lobban ED, Smith BA, Hall GD et al. Uroplakin gene expression by normal and neoplastic human urothelium. Am J Pathol 1998;153:1957-67. (Pubitemid 28550682)
93. Nguyen HT, Park JM, Peters CA et al. Cell-specific activation of the HB-EGF and ErbB1 genes by stretch in primary human bladder cells. In Vitro Cell Dev Biol Anim 1999;35:371-5. (Pubitemid 29379999)
94. Rackley RR, Bandyopadhyay SK, Fazeli-Matin S et al. Immunoregulatory potential of urothelium: characterization of NF-kappaB signal transduction. J Urol 1999;162:1812-6. (Pubitemid 29474734)
95. Lin HK, Cowan R, Moore P et al. Characterization of neuropathic bladder smooth muscle cells in culture. J Urol 2004;171:1348-52. (Pubitemid 38327608)
96. Lai JY, Yoon CY, Yoo JJ et al. Phenotypic and functional characterization of in vivo tissue engineered smooth muscle from normal and pathological bladders. J Urol 2002;168:1853-7; discussion 1858.
97. Brivanlou AH, Gage FH, Jaenisch R et al. Stem cells. Setting standards for human embryonic stem cells [see comment]. Science 2003;300:913-6.
98. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts [see comment] [erratum appears in Science 1998 Dec 4;282(5395):1827]. Science 1998;282:1145-7.
99. Ballas CB, Zielske SP, Gerson SL. Adult bone marrow stem cells for cell and gene therapies: implications for greater use. J Cell Biochem Suppl 2002;38:20-8.
100. Jiao J, Chen DF. Induction of neurogenesis in nonconventional neurogenic regions of the adult central nervous system by niche astrocyte-produced signals. Stem Cells 2008;26:1221-30.
101. Taupin P. Therapeutic potential of adult neural stem cells. Recent Patents CNS Drug Discov 2006;1:299-303.
102. Jensen UB, Yan X, Triel C et al. A distinct population of clonogenic and multipotent murine follicular keratinocytes residing in the upper isthmus. J Cell Science 2008;121:609-17. (Pubitemid 351524159)
103. Crisan M, Casteilla L, Lehr L et al. A reservoir of brown adipocyte progenitors in human skeletal muscle. Stem Cells 2008;26:2425-33.
104. Weiner LP. Definitions and criteria for stem cells. Methods Mol Biol 2008;438:3-8.
105. Devine SM. Mesenchymal stem cells: will they have a role in the clinic? J Cell Biochem Suppl 2002;38:73-9. (Pubitemid 34477669)
106. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow [see comment] [erratum appears in Nature. 2007 Jun 14;447(7146):879-80]. Nature 2002;418:41-9.
107. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007;213:341-7. (Pubitemid 47509711)
108. da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008;26:2287-99.
109. Duan X, Chang JH, Ge S et al. Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain [see comment]. Cell 2007;130:1146-58. (Pubitemid 47422304)
110. Luttun A, Ross JJ, Verfaillie C et al. Unit 22F.9: Differentiation of Multipotent Adult Progenitor Cells into Functional Endothelial and Smooth Muscle Cells. Current Protocols in Immunology, Volume Supplement 75. Hoboken, NJ: John Wiley and Sons, Inc., 2006.
111. Mimeault M, Batra SK. Recent progress on tissue-resident adult stem cell biology and their therapeutic implications. Stem Cell Rev 2008;4:27-49.
112. Ikeda E, Yagi K, Kojima M et al. Multipotent cells from the human third molar: feasibility of cell-based therapy for liver disease. Differentiation 2008;76:495-505. (Pubitemid 351725835)
113. Nolen-Walston RD, Kim CF, Mazan MR et al. Cellular kinetics and modeling of bronchioalveolar stem cell response during lung regeneration. Am J Physiol Lung Cell Mol Physiol 2008;294:L1158-65.
114. in 't Anker PS, Noort WA, Scherjon SA et al. Mesenchymal stem cells in human secondtrimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 2003;88: 845-52.
115. Hristov M, Zernecke A, Schober A et al. Adult progenitor cells in vascular remodeling during atherosclerosis. Biol Chem 2008;389:837-44.
116. De Coppi P, Bartsch G Jr., Siddiqui MM et al. Isolation of amniotic stem cell lines with potential for therapy [see comment]. Nat Biotechnol 2007;25:100-6. (Pubitemid 46087908)
117. Kolambkar YM, Peister A, Soker S et al. Chondrogenic differentiation of amniotic fluidderived stem cells. J Mol Histol 2007;38:405-13. (Pubitemid 350056771)
118. Perin L, Giuliani S, Jin D et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif 2007;40:936-48. (Pubitemid 350139201)
119. Warburton D, Perin L, Defilippo R et al. Stem/progenitor cells in lung development, injury repair, and regeneration. Proc Am Thorac Soc 2008;5:703-6.
120. De Coppi P, Callegari A, Chiavegato A et al. Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol 2007;177:369-76. (Pubitemid 44879501)
121. Hochedlinger K, Rideout WM, Kyba M et al. Nuclear transplantation, embryonic stem cells and the potential for cell therapy. Hemat J 2004;5(Suppl. 3):S114-7. (Pubitemid 39077287)
122. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76. (Pubitemid 44233629)
123. Wernig M, Meissner A, Foreman R et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007;448:318-24. (Pubitemid 47080337)
124. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-72. (Pubitemid 350138099)
125. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007:1151-26.
126. Atala A. Commentary on the replacement of urologic associated mucosa. J Urol 1995;156:338.
127. Sutherland RS, Baskin LS, Hayward SW et al. Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular tissue matrix. J Urol 1996;156:571-7. (Pubitemid 126444879)
128. Wefer J, Sievert KD, Schlote N et al. Time dependent smooth muscle regeneration and maturation in a bladder acellular matrix graft: histological studies and in vivo functional evaluation. J Urol 2001;165:1755-9. (Pubitemid 32410303)
129. Kikuno N, Kawamoto K, Hirata H et al. Nerve growth factor combined with vascular endothelial growth factor enhances regeneration of bladder acellular matrix graft in spinal cord injury-induced neurogenic rat bladder. BJU Int 2008;103:1424-8.
130. Badylak SF, Lantz GC, Coffey A et al. Small intestinal submucosa as a large diameter vascular graft in the dog. J Surg Res 1989;47:74-80. (Pubitemid 19183414)
131. Badylak SF. The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol 2002;13:377-83. (Pubitemid 35300815)
132. Kropp BP, Rippy MK, Badylak SF et al. Regenerative urinary bladder augmentation using small intestinal submucosa: urodynamic and histopathologic assessment in long-term canine bladder augmentations. J Urol 1996;155:2098-104. (Pubitemid 26144128)
133. Kropp BP, Sawyer BD, Shannon HE et al. Characterization of small intestinal submucosa regenerated canine detrusor: assessment of reinnervation, in vitro compliance and contractility. J Urol 1996;156:599-607. (Pubitemid 126444884)
134. Vaught JD, Kropp BP, Sawyer BD et al. Detrusor regeneration in the rat using porcine small intestinal submucosal grafts: functional innervation and receptor expression. J Urol 1996;155:374-8. (Pubitemid 126426497)
135. Portis AJ, Elbahnasy AM, Shalhav AL et al. Laparoscopic augmentation cystoplasty with different biodegradable grafts in an animal model. J Urol 2000;164:1405-11.
136. Landman J, Olweny E, Sundaram CP et al. Laparoscopic mid sagittal hemicystectomy and bladder reconstruction with small intestinal submucosa and reimplantation of ureter into small intestinal submucosa: 1-year followup. J Urol 2004;171:2450-5. (Pubitemid 38625513)
137. Kropp BP, Cheng EY, Lin HK et al. Reliable and reproducible bladder regeneration using unseeded distal small intestinal submucosa. J Urol 2004;172:1710-3. (Pubitemid 39245025)
138. Jayo MJ, Jain D, Wagner BJ et al. Early cellular and stromal responses in regeneration versus repair of a mammalian bladder using autologous cell and biodegradable scaffold technologies [see comment]. J Urol 2008;180:392-7.
139. Zhang Y. Bladder reconstruction by tissue engineering-with or without cells? [comment]. J Urol 2008;180:10-1.
140. Chun SY, Lim GJ, Kwon TG et al. Identification and characterization of bioactive factors in bladder submucosa matrix. Biomaterials 2007;28:4251-6. (Pubitemid 47212395)
141. Nguyen MM, Lieu DK, deGraffenried LA et al. Urothelial progenitor cells: regional differences in the rat bladder. Cell Prolif 2007;40:157-65. (Pubitemid 46398813)
142. Kurzrock EA, Lieu DK, Degraffenried LA et al. Label-retaining cells of the bladder: candidate urothelial stem cells. Am J Physiol Renal Physiol 2008;294:F1415-21.
143. Shukla D, Box GN, Edwards RA et al. Bone marrow stem cells for urologic tissue engineering. World J Urol 2008;26:341-9.
144. Anumanthan G, Makari JH, Honea L et al. Directed differentiation of bone marrow derived mesenchymal stem cells into bladder urothelium. J Urol 2008;180:1778-83.
145. Oottamasathien S, Wang Y, Williams K et al. Directed differentiation of embryonic stem cells into bladder tissue. Dev Biol 2007;304:556-66. (Pubitemid 46527566)
146. de Boer WI, Schuller AG, Vermey M et al. Expression of growth factors and receptors during specific phases in regenerating urothelium after acute injury in vivo. Am J Pathol 1994;145:1199-207. (Pubitemid 24345667)
147. Baker R, Kelly T, Tehan T et al. Subtotal cystectomy and total bladder regeneration in treatment of bladder cancer. J Am Med Assoc 1958;168:1178-85.
148. Gorham SD, French DA, Shivas AA et al. Some observations on the regeneration of smooth muscle in the repaired urinary bladder of the rabbit. Eur Urol 1989;16:440-3. (Pubitemid 19274091)
149. Jayo MJ, Jain D, Ludlow JW et al. Long-term durability, tissue regeneration and neo-organ growth during skeletal maturation with a neo-bladder augmentation construct. Regen Med 2008;3:671-82.
150. Kwon TG, Yoo JJ, Atala A. Local and systemic effects of a tissue engineered neobladder in a canine cystoplasty model. J Urol 2008;179:2035-41.
151. Zhang Y, Frimberger D, Cheng EY et al. Challenges in a larger bladder replacement with cell-seeded and unseeded small intestinal submucosa grafts in a subtotal cystectomy model. BJU Int 2006;98:1100-5. (Pubitemid 44536466)
152. Farhat WA, Yeger H. Does mechanical stimulation have any role in urinary bladder tissue engineering? World J Urol 2008;26:301-5.
153. Atala A, Bauer SB, Soker S et al. Tissue-engineered autologous bladders for patients needing cystoplasty [see comment]. Lancet 2006;367:1241-6.
154. Hipp J, Andersson KE, Kwon TG et al. Microarray analysis of exstrophic human bladder smooth muscle. BJU Int 2008;101:100-5. (Pubitemid 350233566)
155. Dozmorov MG, Kropp BP, Hurst RE et al. Differentially expressed gene networks in cultured smooth muscle cells from normal and neuropathic bladder. J Smooth Muscle Res 2007;43:55-72.
156. Faris RA, Konkin T, Halpert G. Liver stem cells: a potential source of hepatocytes for the treatment of human liver disease [see comment]. Artif Organs 2001;25:513-21. (Pubitemid 33757181)
157. Haller H, de Groot K, Bahlmann F et al. Stem cells and progenitor cells in renal disease. Kidney Int 2005;68:1932-6. (Pubitemid 43117764)